Johnson Andrew S, Tarr Cheryl L, Brown B H, Birkhead Karen M, Farmer J J
Department of Medicine and Pathology, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada.
J Clin Microbiol. 2005 Oct;43(10):5195-201. doi: 10.1128/JCM.43.10.5195-5201.2005.
When enteric group 58 was first described as a distinct new group of Enterobacteriaceae in 1985, there were only five known human isolates: four from wounds and one from feces. In 1996, we investigated the first blood isolate of enteric group 58, a case of sepsis in a 33-year-old woman receiving total parenteral nutrition. Fifteen additional clinical isolates have since been identified at CDC, including several recognized from a collection of "unidentified" strains dating back to 1973. All strains were characterized with a standard set of 49 biochemical tests used for Enterobacteriaceae, and the results were analyzed to determine phenotypic relatedness and best taxonomic fit. Antibiograms were determined as a taxonomic tool. Original identifications provided by submitting laboratories encompassed a wide variety of Enterobacteriaceae, including 14 species in eight genera, the most common being Enterobacter spp., Salmonella spp., Serratia spp., Kluyvera spp., or Escherichia spp. Enteric group 58 strains have been most frequently isolated from traumatic injuries, fractures, and wounds and rarely from feces. Defining its clinical significance and distinguishing infection from colonization requires further study, but our case report indicates that serious systemic infection can occur. The vernacular name enteric group 58 was used from 1985 to 2004. In this paper, we formally name it Averyella dalhousiensis gen. nov., sp. nov., on the basis of its unique phenotype and its unique 16S rRNA gene sequence. These data indicate that enteric group 58 is not closely related to any of the existing genera or species of Enterobacteriaceae. The type strain is designated CDC 9501--97, and a phenotypic definition is given based on all 21 strains.
1985年,肠道菌群58首次被描述为肠杆菌科中一个独特的新菌群,当时已知的人类分离株仅有5株:4株来自伤口,1株来自粪便。1996年,我们对肠道菌群58的首例血液分离株进行了研究,该分离株来自一名接受全胃肠外营养的33岁女性的败血症病例。此后,美国疾病控制与预防中心(CDC)又鉴定出另外15株临床分离株,其中包括几株可追溯到1973年的“未鉴定”菌株。所有菌株均通过一套用于肠杆菌科的49项标准生化试验进行鉴定,并对结果进行分析以确定表型相关性和最佳分类归属。药敏谱被用作一种分类工具。提交实验室提供的原始鉴定涵盖了多种肠杆菌科细菌,包括8个属中的14个种,最常见的是肠杆菌属、沙门氏菌属、沙雷氏菌属、克吕沃菌属或大肠杆菌属。肠道菌群58菌株最常从创伤、骨折和伤口中分离得到,很少从粪便中分离得到。确定其临床意义并区分感染与定植需要进一步研究,但我们的病例报告表明,严重的全身感染可能会发生。1985年至2004年期间使用了通俗名称肠道菌群58。在本文中,我们根据其独特的表型和独特的16S rRNA基因序列,将其正式命名为达豪艾弗里菌属(Averyella dalhousiensis),新属,新种。这些数据表明,肠道菌群58与肠杆菌科现有的任何属或种均无密切关系。模式菌株指定为CDC 9501-97,并根据所有21株菌株给出了表型定义。